Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Apr 20;27(12):2081-90.
doi: 10.1200/JCO.2008.19.8523. Epub 2009 Mar 2.

Malignant pleural mesothelioma

Anne S Tsao  1 , Ignacio Wistuba, Jack A Roth, Hedy Lee Kindler
Affiliations
Review

Malignant pleural mesothelioma

Anne S Tsao et al. J Clin Oncol. .

Abstract

Malignant pleural mesothelioma (MPM) is a deadly disease that occurs in 2,000 to 3,000 people each year in the United States. Although MPM is an extremely difficult disease to treat, with the median overall survival ranging between 9 and 17 months regardless of stage, there has been significant progress over the last few years that has reshaped the clinical landscape. This article will provide a comprehensive discussion of the latest developments in the treatment of MPM. We will provide an update of the major clinical trials that impact mesothelioma treatment in the resectable and unresectable settings, discuss the impact of novel therapeutics, and provide perspective on where the clinical research in mesothelioma is moving. In addition, there are controversial issues, such as the role of extrapleural pneumonectomy, adjuvant radiotherapy, and use of intensity-modulated radiotherapy versus hemithoracic therapy that will also be addressed in this manuscript.

PubMed Disclaimer

Conflict of interest statement

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

References

    1. Weill H, Hughes JM, Churg AM. Changing trends in US mesothelioma incidence. Occup Environ Med. 2004;61:438–441. - PMC - PubMed
    1. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol. 1997;145:211–218. - PubMed
    1. Peto J, Decarli A, La Vecchia C, et al. The European mesothelioma epidemic. Br J Cancer. 1999;79:666–672. - PMC - PubMed
    1. Levin SM, Herbert R, Moline J. Heath Effects among World Trade Center Responders. Lung Cancer. 2006;54(suppl):S10. abstr 36.
    1. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591–1603. - PubMed

MeSH terms